Immediate Impact

3 by Nobel laureates 5 from Science/Nature 76 standout
Sub-graph 1 of 21

Citing Papers

A new era of cancer phototherapy: mechanisms and applications
2024 Standout
New promises and challenges in the treatment of advanced non-small-cell lung cancer
2024 Standout
7 intermediate papers

Works of Richard Schaub being referenced

First-in-Human Phase I Study of the Oral Inhibitor of Indoleamine 2,3-Dioxygenase-1 Epacadostat (INCB024360) in Patients with Advanced Solid Malignancies
2017
Phase I study of the safety, pharmacokinetics (PK), and pharmacodynamics (PD) of the oral inhibitor of indoleamine 2,3-dioxygenase (IDO1) INCB024360 in patients (pts) with advanced malignancies.
2013

Author Peers

Author Last Decade Papers Cites
Richard Schaub 165 142 69 124 9 313
Nikolaus von Knebel Doeberitz 90 135 49 104 7 332
Lara Stepan 159 76 46 49 7 307
Annabel Meireson 169 59 29 124 9 281
Mariangela Lecciso 100 55 25 168 13 353
Radhakrishna G. Pillai 70 80 14 60 11 368
David Agdashian 198 27 20 169 6 330
Günter Küblbeck 55 33 10 187 13 366
JungAh Jung 137 34 8 20 12 313
Baptiste Hamelin 123 10 76 45 10 323
Isabelle Rottiers 107 27 9 33 10 303

All Works

Loading papers...

Rankless by CCL
2026